http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0074426-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-10
filingDate 1981-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1985-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1985-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0074426-B1
titleOfInvention Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
abstract This invention relates to novel agents and oral dosage forms of an active substance for treating patients suffering from abnormal distribution and retention of body fluids or retention products. Furthermore, oral dosage forms of the invention are useful for prophylactic treatment of patients liable to contract renal failure. The invention also enables prophylactic treatment and treatment of patients having or being inclined to form kidney stones. In general, the common feature of the variety of ailments which can be treated or the corrective measures which can be taken are associated with altered renal function or renal insufficiency.
priorityDate 1981-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73896894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19710891
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412514
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226598699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226431830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16211203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87113380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22178470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10690
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226790061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395133
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411712

Total number of triples: 49.